Correction: NT-I7, a novel long-acting interleukin-7, promotes anti-PD-1 efficacy in an autologous humanized melanoma model.

Phoon YP; Wolfarth AA; Funchain P; Ko JS; Choi D; Dedkova E; Bateman DD; Corvin J; Melenhorst JJ; Gastman BR

doi:10.1038/s41598-025-33043-1

← 뒤로

Correction: NT-I7, a novel long-acting interleukin-7, promotes anti-PD-1 efficacy in an autologous humanized melanoma model.

Scientific reports 2025 Vol.15(1) p. 44038

Phoon YP, Wolfarth AA, Funchain P, Ko JS, Choi D, Dedkova E, Bateman DD, Corvin J, Melenhorst JJ, Gastman BR

PMC 전문 ↗ 원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

BibTeX ↓ RIS ↓

APA Phoon YP, Wolfarth AA, et al. (2025). Correction: NT-I7, a novel long-acting interleukin-7, promotes anti-PD-1 efficacy in an autologous humanized melanoma model.. Scientific reports, 15(1), 44038. https://doi.org/10.1038/s41598-025-33043-1

MLA Phoon YP, et al.. "Correction: NT-I7, a novel long-acting interleukin-7, promotes anti-PD-1 efficacy in an autologous humanized melanoma model.." Scientific reports, vol. 15, no. 1, 2025, pp. 44038.

PMID 41413171

DOI 10.1038/s41598-025-33043-1

같은 제1저자의 인용 많은 논문 (1)

NT-I7, a novel long-acting interleukin-7, promotes anti-PD-1 efficacy in an autologous humanized melanoma model.
Scientific reports 2025